JFNCX
Janus Henderson Global Life Sciences Fund - C Shares
$77.04
Janus Henderson Global Life Sciences Fund - C Shares (JFNCX)
The fund endeavors to generate long-term capital appreciation. To achieve this, it typically commits at least 80% of its net assets, along with any borrowed capital for investment, to securities of companies its portfolio managers deem to be focused on life sciences. As a foundational aspect of its investment approach, the fund has a policy to generally deploy at least 25% of its total assets into companies formally categorized within the "life sciences" sector.
JFNCX Mutual Fund Chart & Stats
$77.04
At close: 4:00 PM EST- Previous Close
- $77.04
- Sub-Category
- Global,International
- Total Liabilities
- $11.19M
- Last Dividend Ex-Date
- Dec 05, 2025
- Expense Ratio
- 1.79%
- Holding Count
- 84
- Brand
- Janus Investment Fund
- Dividend Yield
- (4.32%)
- Category
- Equity
- Total Assets
- 5.82B
- Shares Outstanding
- N/A
- 52-Week Range
- $62.48 - $79.66
JFNCX Mutual Fund News
JFNCX Mutual Fund Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| LLYEli Lilly And Company | 9.41% |
| JNJJohnson & Johnson | 7.09% |
| ABBVAbbvie | 4.67% |
| UNHUnitedhealth Group Inc. | 4.54% |
| AZNAstraZeneca plc | 3.93% |
| RVMDRevolution Medicines, Inc. | 3.02% |
| ARGXArgenx | 2.63% |
| NVSNovartis AG | 2.56% |
| TMOThermo Fisher Scientific | 2.33% |
| PRAXPraxis Precision Medicines, Inc. | 2.19% |
| Total | 42.37% |
Recently Viewed
No data currently available






